Imatinib as a paradigm of targeted therapies

Brian J. Druker

doi:10.1200/JCO.2003.10.589

Imatinib as a paradigm of targeted therapies

Brian J. Druker

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Original language	English (US)
Pages (from-to)	239s-245s
Journal	Journal of Clinical Oncology
Volume	21
Issue number	23
DOIs	https://doi.org/10.1200/JCO.2003.10.589
State	Published - Dec 1 2003

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2003.10.589

Cite this

@article{27fb21ec3bdf41cabadc82dcb5223389,

title = "Imatinib as a paradigm of targeted therapies",

author = "Druker, {Brian J.}",

year = "2003",

month = dec,

day = "1",

doi = "10.1200/JCO.2003.10.589",

language = "English (US)",

volume = "21",

pages = "239s--245s",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "23",

}

TY - JOUR

T1 - Imatinib as a paradigm of targeted therapies

AU - Druker, Brian J.

PY - 2003/12/1

Y1 - 2003/12/1

UR - http://www.scopus.com/inward/record.url?scp=0642307264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642307264&partnerID=8YFLogxK

U2 - 10.1200/JCO.2003.10.589

DO - 10.1200/JCO.2003.10.589

M3 - Article

C2 - 14645403

AN - SCOPUS:0642307264

SN - 0732-183X

VL - 21

SP - 239s-245s

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 23

ER -

Imatinib as a paradigm of targeted therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this